Enzon Pharmaceuticals (ENZN)

Enzon Pharmaceuticals (ENZN) Financial Statements


Enzon Pharmaceuticals Financial Overview

Enzon Pharmaceuticals's market cap is currently ―. The company's EPS TTM is $-0.007; its P/E ratio is -18.46; Enzon Pharmaceuticals is scheduled to report earnings on November 8, 2023, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 23Mar 23Dec 22Sep 22Jun 22
Income Statement-
Total Revenue--$ 26.00K$ 0.00$ 0.00
Gross Profit--$ 26.00K--
EBIT$ 235.00K$ 162.00K$ 135.00K$ -221.00K$ -303.00K
EBITDA-$ 162.00K$ 135.00K$ -221.00K$ -303.00K
Net Income Common Stockholders$ -348.00K$ -334.00K$ 651.00K$ -546.00K$ -744.00K
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 46.13M$ 45.88M$ 46.98M$ 46.85M$ 46.79M
Total Assets$ 46.67M$ 46.49M$ 47.59M$ 47.26M$ 47.22M
Total Debt$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Net Debt$ -46.13M$ -45.88M$ -46.98M$ -46.85M$ -46.79M
Total Liabilities$ 402.00K$ 408.00K$ 1.70M$ 425.00K$ 377.00K
Stockholders Equity$ 2.73M$ 3.07M$ 3.41M$ 46.83M$ 46.85M
Cash Flow-
Free Cash Flow-$ 170.00K$ 130.00K$ 58.00K$ -635.00K
Operating Cash Flow-$ 170.00K$ 130.00K$ 58.00K$ -635.00K
Investing Cash Flow-----
Financing Cash Flow-$ -1.27M---
Currency in USD

Enzon Pharmaceuticals Earnings and Revenue History

Enzon Pharmaceuticals Debt to Assets

Enzon Pharmaceuticals Cash Flow

Enzon Pharmaceuticals Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis